GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » YoY Rev. per Sh. Growth

Theratechnologies (Theratechnologies) YoY Rev. per Sh. Growth : -60.02% (As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Theratechnologies's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 was -60.02%.

Theratechnologies's Revenue per Share for the three months ended in Feb. 2024 was $0.33.

Theratechnologies YoY Rev. per Sh. Growth Historical Data

The historical data trend for Theratechnologies's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies YoY Rev. per Sh. Growth Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.99 4.41 -11.89 11.18 -7.64

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.51 -10.49 -1.49 -19.98 -60.02

Theratechnologies YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Theratechnologies's YoY Rev. per Sh. Growth for the fiscal year that ended in Nov. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Nov. 2023 )
=(Revenue per Share (A: Nov. 2023 )-Revenue per Share (A: Nov. 2022 ))/ | Revenue per Share (A: Nov. 2022 ) |
=(3.105-3.362)/ | 3.362 |
=-7.64 %

Theratechnologies's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Feb. 2024 )
=(Revenue per Share (Q: Feb. 2024 )-Revenue per Share (Q: Feb. 2023 )) / | Revenue per Share (Q: Feb. 2023 )) |
=(0.329-0.823)/ | 0.823 |
=-60.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theratechnologies YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Theratechnologies's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TSX:SVA TSXV:MIR XCNQ:METX TSXV:ARCH XCNQ:DTC TSX:MSCL TSX:ONC XCNQ:ACOG TSX:HBP TSX:MBX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TQ80:Germany TH:Canada
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.